Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Innovations (Philadelphia, Pa.)|January 27, 2022
Utilization of EKOS in Patients With Pulmonary EmbolismKirsten E Robles, Anastasia L Armbruster, Shane E Austin, et al.
Journal of Clinical Pharmacy and Therapeutics|May 7, 2019
Evaluation of the effect of prior antiarrhythmic drug use on the success of atrial fibrillation catheter ablationMichelle Wang, Katie B Tellor, Karthik Ramaswamy, et al.
American Health & Drug Benefits|December 20, 2014
Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital settingAnastasia L Armbruster, Katie S Buehler, Sun H Min, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 12, 2020
Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart DiseaseMeredith L Hampton, Katie B Tellor, Anastasia L Armbruster, et al.
Journal of Clinical Pharmacy and Therapeutics|April 11, 2019
A rare case of a gabapentin-induced cardiomyopathyKatie B Tellor, Richard Ngo-Lam, Dena Badran, et al.
Therapeutic Advances in Cardiovascular Disease|June 20, 2018
Evaluation of the impact of body mass index on warfarin requirements in hospitalized patientsKatie B Tellor, Steffany N Nguyen, Amanda C Bultas, et al.
American Journal of Pharmaceutical Education|November 5, 2020
Predictors of Student Failure or Poor Performance on Advanced Pharmacy Practice ExperiencesWilliam B Call, Gloria R Grice, Katie B Tellor, et al.
Currents in Pharmacy Teaching & Learning|April 28, 2020
Assessment of a multi-institution integration of cultural competency activitiesLakesha Butler, Aleda M H Chen, Nancy Borja-Hart, et al.
Currents in Pharmacy Teaching & Learning|September 17, 2023
Assessing the utility of pre-course assessment and voluntary pre-work in two required integrated pharmacotherapy coursesLaura M Challen, Joseph S Van Tuyl, Suzanne G Bollmeier, et al.
European Journal of Clinical Pharmacology|January 15, 2021
Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney diseaseAmanda R Buckallew, Katie B Tellor, Rachel Watson, et al.
Pageof 3